Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape.

Saved in:
Bibliographic Details
Title: Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape.
Authors: Soulen MC; Interventional Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; and michael.soulen@pennmedicine.upenn.edu., Rilling WS; Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 270-271. Date of Electronic Publication: 2024 Feb 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.123.267035